1
|
Bedingfield N, Lashewicz B, Fisher D, King-Shier K. Systems of support for foreign-born TB patients and their family members. Public Health Action 2022; 12:79-84. [PMID: 35734012 PMCID: PMC9176195 DOI: 10.5588/pha.21.0081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Accepted: 03/14/2022] [Indexed: 01/24/2023] Open
Abstract
SETTING Adverse social determinants of health for people who are foreign-born are key drivers of TB-related disparity, particularly in low-incidence countries. Patients diagnosed with infectious TB and their family members must confront psychosocial challenges which may deepen pre-existing health inequities. However, little is known about patient and family members' perspective on these experiences. OBJECTIVE To explore the infectious TB experience of patients and family members who are foreign-born. DESIGN This study formed one component of an ecologically framed, qualitative case study conducted in Calgary, AB, Canada. Data were collected using semi-structured interviews, chart review and field notes, and analysed thematically. RESULTS Eight families were represented in the sample comprised of six patients and 13 family members. Many patients and family members experienced high levels of fear and stress for months following the patient's diagnosis. Isolation was pervasive and multifaceted for both patients and family members. Intra-family support was critical for managing during early stages when the situation was most challenging. Support from outside the family was not prominent and attempts to obtain support from government programmes for paid sick leave and health insurance were mostly unsuccessful. CONCLUSION Patients and family members who are foreign-born experience multidimensional isolation as a result of TB stigma, language barriers and poor access to government programmes. TB programmes cannot meet family needs alone and systems of support should be created through collaboration with government institutions, and organisations serving ethnocultural communities.
Collapse
Affiliation(s)
- N. Bedingfield
- Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada
| | - B. Lashewicz
- Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada
| | - D. Fisher
- Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada
,Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
| | - K. King-Shier
- Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada
, Faculty of Nursing, University of Calgary, Professional Faculties Calgary, AB, Canada
| |
Collapse
|
2
|
Bedingfield N, Barss L, Oxlade O, Menzies D, Fisher D. Experiences with latent TB cascade of care strengthening for household contacts in Calgary, Canada. Public Health Action 2021; 11:126-131. [PMID: 34567988 DOI: 10.5588/pha.20.0082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2020] [Accepted: 04/11/2021] [Indexed: 11/10/2022] Open
Abstract
SETTING Identification, assessment, and treatment of latent TB infection (LTBI), collectively known as the LTBI cascade of care, is critical for TB prevention. OBJECTIVE The objective of this research, conducted within the ACT4 trial, was to assess and strengthen the LTBI cascade of care for household contacts at Calgary TB Services, a clinic serving a predominately foreign-born population in Western Canada. DESIGN Baseline assessment consisted of a retrospective LTBI cascade analysis of 32 contact investigations, and questionnaires administered to patients and health care workers. Four solutions were implemented in response to identified gaps. Solution impact was measured for 6 months using descriptive statistics. RESULTS Pre-implementation, 56% of household contacts initiated treatment. Most contacts were lost to care because the tuberculin skin test (TST) was not initiated, or physicians did not recommend treatment. Evening clinics, a patient education pamphlet, a nursing workshop, and treatment recommendation guidelines were implemented. Post-implementation, losses due to LTBI treatment non-recommendation were reduced; however, the overall proportion of household contacts initiating treatment did not increase. CONCLUSION Close engagement between researchers and TB programmes can reduce losses in the LTBI cascade. To see sustained improvement in overall outcomes, long-term engagement and data collection for ongoing problem-solving are required.
Collapse
Affiliation(s)
- N Bedingfield
- Department of Community Health Sciences, Cumming School of Medicine, University of Calgary Foothills Campus, Health Sciences Centre, Calgary, AB, Canada
| | - L Barss
- Department of Medicine, Cumming School of Medicine, University of Calgary Foothills Campus, Health Sciences Centre, Calgary, AB, Canada
| | - O Oxlade
- McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada
| | - D Menzies
- McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada
| | - D Fisher
- Department of Community Health Sciences, Cumming School of Medicine, University of Calgary Foothills Campus, Health Sciences Centre, Calgary, AB, Canada.,Department of Medicine, Cumming School of Medicine, University of Calgary Foothills Campus, Health Sciences Centre, Calgary, AB, Canada
| |
Collapse
|
3
|
Alsdurf H, Oxlade O, Adjobimey M, Ahmad Khan F, Bastos M, Bedingfield N, Benedetti A, Boafo D, Buu TN, Chiang L, Cook V, Fisher D, Fox GJ, Fregonese F, Hadisoemarto P, Johnston JC, Kassa F, Long R, Moayedi Nia S, Nguyen TA, Obeng J, Paulsen C, Romanowski K, Ruslami R, Schwartzman K, Sohn H, Strumpf E, Trajman A, Valiquette C, Yaha L, Menzies D. Resource implications of the latent tuberculosis cascade of care: a time and motion study in five countries. BMC Health Serv Res 2020; 20:341. [PMID: 32316963 PMCID: PMC7175545 DOI: 10.1186/s12913-020-05220-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2020] [Accepted: 04/13/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The End TB Strategy calls for global scale-up of preventive treatment for latent tuberculosis infection (LTBI), but little information is available about the associated human resource requirements. Our study aimed to quantify the healthcare worker (HCW) time needed to perform the tasks associated with each step along the LTBI cascade of care for household contacts of TB patients. METHODS We conducted a time and motion (TAM) study between January 2018 and March 2019, in which consenting HCWs were observed throughout a typical workday. The precise time spent was recorded in pre-specified categories of work activities for each step along the cascade. A linear mixed model was fit to estimate the time at each step. RESULTS A total of 173 HCWs in Benin, Canada, Ghana, Indonesia, and Vietnam participated. The greatest amount of time was spent for the medical evaluation (median: 11 min; IQR: 6-16), while the least time was spent on reading a tuberculin skin test (TST) (median: 4 min; IQR: 2-9). The greatest variability was seen in the time spent for each medical evaluation, while TST placement and reading showed the least variability. The total time required to complete all steps along the LTBI cascade, from identification of household contacts (HHC) through to treatment initiation ranged from 1.8 h per index TB patient in Vietnam to 5.2 h in Ghana. CONCLUSIONS Our findings suggest that the time requirements are very modest to perform each step in the latent TB cascade of care, but to achieve full identification and management of all household contacts will require additional human resources in many settings.
Collapse
Affiliation(s)
- H Alsdurf
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
| | - O Oxlade
- McGill International TB Centre, McGill University, 5252 Boulevard de Maisonneuve, Room 3D.58, Montreal, QC, Canada.,Respiratory Epidemiology and Clinical Research Unit (RECRU), McGill University, Montreal, QC, Canada
| | - M Adjobimey
- Programme National contre la Tuberculose-Bénin, Centre National Hospitalier Universitaire de Pneumo-Phtisiologie-Cotonou, Cotonou, Benin
| | - F Ahmad Khan
- McGill International TB Centre, McGill University, 5252 Boulevard de Maisonneuve, Room 3D.58, Montreal, QC, Canada
| | - M Bastos
- Respiratory Epidemiology and Clinical Research Unit (RECRU), McGill University, Montreal, QC, Canada.,Social Medicine Institute, State University of Rio de Janeiro, Rio de Janeiro, Brazil
| | | | - A Benedetti
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.,McGill International TB Centre, McGill University, 5252 Boulevard de Maisonneuve, Room 3D.58, Montreal, QC, Canada
| | - D Boafo
- Chest Clinic, Komfo Anokye Teaching Hospital, Kumasi, Ghana
| | - T N Buu
- Woolcock Institute of Medical Research, Hanoi, Vietnam
| | - L Chiang
- Provincial Tuberculosis Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada
| | - V Cook
- Provincial Tuberculosis Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.,Department of Medicine, University of British Columbia, Vancouver, BC, Canada
| | - D Fisher
- Division of Respiratory Medicine, University of Calgary, Calgary, AB, Canada
| | - G J Fox
- The Faculty of Medicine and Health, The University of Sydney Central Clinical School, The University of Sydney, Sydney, NSW, Australia
| | - F Fregonese
- McGill International TB Centre, McGill University, 5252 Boulevard de Maisonneuve, Room 3D.58, Montreal, QC, Canada
| | - P Hadisoemarto
- Department of Public Health, Faculty of Medicine, TB-HIV Research Center, Universitas Padjadjaran, Bandung, Indonesia
| | - J C Johnston
- Provincial Tuberculosis Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada
| | - F Kassa
- Programme National contre la Tuberculose-Bénin, Centre National Hospitalier Universitaire de Pneumo-Phtisiologie-Cotonou, Cotonou, Benin
| | - R Long
- Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
| | - S Moayedi Nia
- Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC, Canada
| | - T A Nguyen
- Woolcock Institute of Medical Research, Hanoi, Vietnam
| | - J Obeng
- Chest Clinic, Komfo Anokye Teaching Hospital, Kumasi, Ghana
| | - C Paulsen
- Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
| | - K Romanowski
- Provincial Tuberculosis Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada
| | - R Ruslami
- Department of Biomedical Sciences, Division of Pharmacology & Therapy, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
| | - K Schwartzman
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.,McGill International TB Centre, McGill University, 5252 Boulevard de Maisonneuve, Room 3D.58, Montreal, QC, Canada.,Respiratory Epidemiology and Clinical Research Unit (RECRU), McGill University, Montreal, QC, Canada
| | - H Sohn
- Department of Epidemiology, John Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - E Strumpf
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
| | - A Trajman
- Social Medicine Institute, State University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - C Valiquette
- McGill International TB Centre, McGill University, 5252 Boulevard de Maisonneuve, Room 3D.58, Montreal, QC, Canada
| | - L Yaha
- Programme National contre la Tuberculose-Bénin, Centre National Hospitalier Universitaire de Pneumo-Phtisiologie-Cotonou, Cotonou, Benin
| | - D Menzies
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada. .,McGill International TB Centre, McGill University, 5252 Boulevard de Maisonneuve, Room 3D.58, Montreal, QC, Canada. .,Respiratory Epidemiology and Clinical Research Unit (RECRU), McGill University, Montreal, QC, Canada.
| |
Collapse
|
4
|
Henderson RI, Shea-Budgell M, Healy C, Letendre A, Bill L, Healy B, Bednarczyk RA, Mrklas K, Barnabe C, Guichon J, Bedingfield N, MacDonald S, Colquhoun A, Glaze S, Nash T, Bell C, Kellner J, Richardson R, Dixon T, Starlight J, Runner G, Nelson G. First nations people's perspectives on barriers and supports for enhancing HPV vaccination: Foundations for sustainable, community-driven strategies. Gynecol Oncol 2018; 149:93-100. [PMID: 29605057 DOI: 10.1016/j.ygyno.2017.12.024] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2017] [Revised: 11/17/2017] [Accepted: 12/19/2017] [Indexed: 10/17/2022]
Abstract
OBJECTIVE In Canada, Indigenous people have higher human papillomavirus (HPV) infection rates, lower screening rates for cervical cancer, and higher rates of invasive cancer, leading to worse cervical cancer-related outcomes than observed in non-Indigenous Canadian women. Lingering harms from European colonization drive these health inequities and create public health challenges. Policy guidance is needed to optimize HPV vaccination rates and, thereby, decrease the burden of HPV-related illness, including high-morbidity surgical procedures and chemo-radiotherapy. The Enhancing HPV Vaccination In First Nations Populations in Alberta (EHVINA) project focuses on First Nations, a diverse subset of recognized Indigenous people in Canada, and seeks to increase HPV vaccination among girls and boys living in First Nation communities. METHODS Developing an effective strategy requires partnership with affected communities to better understand knowledge and perceptions about cancer, healthcare, and the HPV vaccine. A 2017 community gathering was convened to engage First Nations community members, health directors, and health services researchers in dialogue around unique barriers and supports to HPV vaccination in Alberta. Voices of community Elders, parents, health directors, and cancer survivors (n=24) are presented as qualitative evidence to help inform intervention design. RESULTS Key findings from discussions indicate barriers to HPV vaccination include resource constraints and service infrastructure gaps, historical mistrust in healthcare systems, impacts of changing modes of communication, and community sensitivities regarding sexual health promotion. Supports were identified as strengthened inter-generational relationships in communities. CONCLUSIONS AND FUTURE DIRECTION Ongoing dialogue and co-development of community-based strategies to increase HPV vaccine uptake are required. The identification of possible barriers to HPV vaccination in a Canadian Indigenous population contributes to limited global literature on this subject and may inform researchers and policy makers who work with Indigenous populations in other regions.
Collapse
Affiliation(s)
- R I Henderson
- Department of Family Medicine, Cumming School of Medicine, Calgary, AB, Canada.
| | - M Shea-Budgell
- Department of Oncology, Cumming School of Medicine, Calgary, AB, Canada
| | - C Healy
- Alberta First Nations Information Governance Centre, Calgary, AB, Canada
| | - A Letendre
- Alberta Cancer Prevention Legacy Fund, Edmonton, AB, Canada
| | - L Bill
- Alberta First Nations Information Governance Centre, Calgary, AB, Canada
| | - B Healy
- Alberta First Nations Information Governance Centre, Calgary, AB, Canada
| | - R A Bednarczyk
- Rollins School of Public Health, Emory University, Atlanta, GA, United States
| | - K Mrklas
- Department of Community Health Sciences, Cumming School of Medicine, Calgary, AB, Canada
| | - C Barnabe
- Department of Medicine, Cumming School of Medicine, Calgary, AB, Canada
| | - J Guichon
- Department of Community Health Sciences, Cumming School of Medicine, Calgary, AB, Canada
| | - N Bedingfield
- Department of Community Health Sciences, Cumming School of Medicine, Calgary, AB, Canada
| | - S MacDonald
- Faculty of Nursing, University of Alberta, Edmonton, AB, Canada
| | - A Colquhoun
- Alberta Ministry of Health, Edmonton, AB, Canada
| | - S Glaze
- Department of Oncology, Cumming School of Medicine, Calgary, AB, Canada
| | - T Nash
- Indigenous Mental Health Program, Calgary, AB, Canada
| | - C Bell
- Alberta Ministry of Health, Edmonton, AB, Canada
| | - J Kellner
- Department of Pediatrics, Cumming School of Medicine, Calgary, AB, Canada
| | - R Richardson
- First Nations and Inuit Health Branch, Alberta Region, Edmonton, AB, Canada
| | - T Dixon
- Elder, Eden Valley Nation, AB, Canada
| | | | - G Runner
- Elder, Tsuut'ina Nation, AB, Canada
| | - G Nelson
- Department of Oncology, Cumming School of Medicine, Calgary, AB, Canada
| |
Collapse
|